Group 1 - The company held its second extraordinary general meeting of shareholders on July 16, 2025, where five non-employee representative directors were elected to form the sixth board of directors [1] - The sixth board consists of six directors, including four non-independent directors and two independent directors, with the term lasting three years from the date of approval [1][2] - The board's composition meets regulatory requirements regarding the proportion of independent directors and the qualifications of independent director candidates have been approved by the Shenzhen Stock Exchange [1][2] Group 2 - The company appointed senior management personnel, including the general manager, deputy general managers, and the head of the audit department, all for a term of three years [2][3] - The general manager is Mr. Xu Ronghuang, with Mr. Chen Xiliang serving as the deputy general manager and financial director [2][3] - The company’s secretary of the board and securities affairs representative have obtained the necessary qualifications as per regulatory requirements [3] Group 3 - Following the board re-election, Mr. Xu Danqing and Mr. Xu Songqing stepped down from their respective positions but will continue to work within the company [4][5] - Mr. Xu Danqing holds 139,973,400 shares, accounting for 27.30% of the total share capital, while Mr. Xu Songqing holds 40,572,000 shares, representing 7.91% [4][5] - The company expressed gratitude for the contributions made by the departing directors during their tenure [5] Group 4 - The resumes of the newly appointed directors and senior management personnel are available in the attachment, detailing their qualifications and professional backgrounds [5][6] - Mr. Xu Ronghuang, the chairman, has been with the company since 2015 and has held various positions before becoming the general manager [6][13] - The independent directors, including Ms. Zhao Xiaobo and Mr. Lai Hanqi, have no conflicts of interest with major shareholders or other directors [11][12]
特一药业: 关于董事会完成换届选举及聘任高级管理人员、证券事务代表、审计部负责人的公告